These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 30693367)
1. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367 [TBL] [Abstract][Full Text] [Related]
2. Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy. Bao Z; Li H; Hu J; Zhao R; Yan L; Zheng A PLoS One; 2024; 19(6):e0304869. PubMed ID: 38837984 [TBL] [Abstract][Full Text] [Related]
3. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children. Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315 [TBL] [Abstract][Full Text] [Related]
4. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy. Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219 [TBL] [Abstract][Full Text] [Related]
5. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy. Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178 [TBL] [Abstract][Full Text] [Related]
6. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570 [TBL] [Abstract][Full Text] [Related]
7. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis. Wen Z; Chen J; Zhu B; Lu Y; Chen L Medicine (Baltimore); 2021 May; 100(20):e25831. PubMed ID: 34011048 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese. Li X; Zhang J; Wu X; Yan H; Zhang Y; He RH; Tang YJ; He YJ; Tan D; Mao XY; Yin JY; Liu ZQ; Zhou HH; Liu J Pharmacogenomics; 2016 Dec; 17(18):2007-2014. PubMed ID: 27918244 [TBL] [Abstract][Full Text] [Related]
9. Association Between Li M; Zhong R; Lu Y; Zhao Q; Li G; Lin W Front Neurol; 2020; 11():591828. PubMed ID: 33519675 [No Abstract] [Full Text] [Related]
10. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis. Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604 [TBL] [Abstract][Full Text] [Related]
11. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934 [TBL] [Abstract][Full Text] [Related]
12. Association between Genetic Polymorphism of Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283 [No Abstract] [Full Text] [Related]
13. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis. Yang R; Qian R; Chen K; Yi W; Sima X Neurol Sci; 2021 Jul; 42(7):2705-2711. PubMed ID: 33914194 [TBL] [Abstract][Full Text] [Related]
14. Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. Baum L; Haerian BS; Ng HK; Wong VC; Ng PW; Lui CH; Sin NC; Zhang C; Tomlinson B; Wong GW; Tan HJ; Raymond AA; Mohamed Z; Kwan P Hum Genet; 2014 May; 133(5):651-9. PubMed ID: 24337656 [TBL] [Abstract][Full Text] [Related]
15. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis. Zhang X; Liu J; Ye J Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210 [TBL] [Abstract][Full Text] [Related]
16. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis. Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436 [TBL] [Abstract][Full Text] [Related]
17. Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures. Kong Y; Yan K; Hu L; Wang M; Dong X; Lu Y; Wu B; Wang H; Yang L; Zhou W Clin Chim Acta; 2018 Aug; 483():14-19. PubMed ID: 29649454 [TBL] [Abstract][Full Text] [Related]
18. SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study. Haerian BS; Baum L; Tan HJ; Kwan P; Raymond AA; Saruwatari J; Nakagawa K; Mohamed Z Pharmacogenomics; 2012 Oct; 13(13):1477-85. PubMed ID: 23057548 [TBL] [Abstract][Full Text] [Related]
19. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population. Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305 [TBL] [Abstract][Full Text] [Related]
20. Association of Katsarou MS; Siatouni A; Tsikrika D; Kokkiou E; Stefanatou M; Verentzioti A; Alexoudi A; Gatzonis S; Drakoulis N; Papasavva M Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336815 [No Abstract] [Full Text] [Related] [Next] [New Search]